Buaya, Stephanie Jane A.

HRN: 05-24-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
CEFTRIAXONE 1G (VIAL)
09/04/2023
09/12/2023
IV
2gm
OD
Cholelithiasis Cholecystitis
Waiting Final Action 
09/04/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/04/2023
09/12/2023
IV
500mg
Q8
Cholelithiasis Cholecystitis
Waiting Final Action 
09/10/2023
METRONIDAZOLE 500MG (TAB)
09/10/2023
09/12/2023
ORAL
500mg
TID
S/p Cholecystectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: